Subjects -> MEDICAL SCIENCES (Total: 8677 journals)
    - ALLERGOLOGY AND IMMUNOLOGY (219 journals)
    - ANAESTHESIOLOGY (120 journals)
    - CARDIOVASCULAR DISEASES (338 journals)
    - CHIROPRACTIC, HOMEOPATHY, OSTEOPATHY (21 journals)
    - COMMUNICABLE DISEASES, EPIDEMIOLOGY (235 journals)
    - DENTISTRY (294 journals)
    - DERMATOLOGY AND VENEREOLOGY (164 journals)
    - EMERGENCY AND INTENSIVE CRITICAL CARE (124 journals)
    - ENDOCRINOLOGY (151 journals)
    - FORENSIC SCIENCES (42 journals)
    - GASTROENTEROLOGY AND HEPATOLOGY (189 journals)
    - GERONTOLOGY AND GERIATRICS (138 journals)
    - HEMATOLOGY (157 journals)
    - HYPNOSIS (4 journals)
    - INTERNAL MEDICINE (177 journals)
    - LABORATORY AND EXPERIMENTAL MEDICINE (99 journals)
    - MEDICAL GENETICS (58 journals)
    - MEDICAL SCIENCES (2410 journals)
    - NURSES AND NURSING (367 journals)
    - OBSTETRICS AND GYNECOLOGY (207 journals)
    - ONCOLOGY (386 journals)
    - OPHTHALMOLOGY AND OPTOMETRY (141 journals)
    - ORTHOPEDICS AND TRAUMATOLOGY (170 journals)
    - OTORHINOLARYNGOLOGY (83 journals)
    - PATHOLOGY (100 journals)
    - PEDIATRICS (275 journals)
    - PHYSICAL MEDICINE AND REHABILITATION (158 journals)
    - PSYCHIATRY AND NEUROLOGY (833 journals)
    - RADIOLOGY AND NUCLEAR MEDICINE (192 journals)
    - RESPIRATORY DISEASES (104 journals)
    - RHEUMATOLOGY (79 journals)
    - SPORTS MEDICINE (81 journals)
    - SURGERY (406 journals)
    - UROLOGY, NEPHROLOGY AND ANDROLOGY (155 journals)

CARDIOVASCULAR DISEASES (338 journals)                  1 2 | Last

Showing 1 - 200 of 338 Journals sorted alphabetically
Acta Angiologica     Open Access   (Followers: 5)
Acta Cardiologica     Hybrid Journal   (Followers: 2)
Acute Cardiac Care     Hybrid Journal   (Followers: 8)
Adipositas - Ursachen, Folgeerkrankungen, Therapie     Hybrid Journal  
AJP Heart and Circulatory Physiology     Hybrid Journal   (Followers: 12)
Aktuelle Kardiologie     Hybrid Journal   (Followers: 1)
American Heart Journal     Hybrid Journal   (Followers: 60)
American Journal of Cardiology     Hybrid Journal   (Followers: 68)
American Journal of Cardiovascular Drugs     Hybrid Journal   (Followers: 18)
American Journal of Hypertension     Hybrid Journal   (Followers: 29)
Anales de Cirugia Vascular     Full-text available via subscription   (Followers: 1)
Anatolian Journal of Cardiology     Open Access   (Followers: 6)
Angiología     Full-text available via subscription  
Angiologia e Cirurgia Vascular     Open Access   (Followers: 1)
Angiology     Hybrid Journal   (Followers: 3)
Annales de Cardiologie et d'Angéiologie     Full-text available via subscription   (Followers: 1)
Annals of Circulation     Open Access   (Followers: 2)
Annals of Noninvasive Electrocardiology     Hybrid Journal   (Followers: 1)
Annals of Pediatric Cardiology     Open Access   (Followers: 12)
AORTA     Open Access  
Archives of Cardiovascular Diseases     Full-text available via subscription   (Followers: 6)
Archives of Cardiovascular Diseases Supplements     Full-text available via subscription   (Followers: 4)
Archives of Cardiovascular Imaging     Open Access   (Followers: 2)
Archivos de cardiología de México     Open Access   (Followers: 1)
Argentine Journal of Cardiology (English edition)     Open Access   (Followers: 2)
Arquivos Brasileiros de Cardiologia     Open Access   (Followers: 2)
Arrhythmia & Electrophysiology Review     Open Access   (Followers: 1)
Arteriosclerosis, Thrombosis and Vascular Biology     Full-text available via subscription   (Followers: 33)
Artery Research     Hybrid Journal   (Followers: 5)
ARYA Atherosclerosis     Open Access  
ASAIO Journal     Hybrid Journal   (Followers: 4)
ASEAN Heart Journal     Open Access   (Followers: 3)
Asian Cardiovascular and Thoracic Annals     Hybrid Journal   (Followers: 2)
Aswan Heart Centre Science & Practice Services     Open Access   (Followers: 1)
Atherosclerosis : X     Open Access  
Bangladesh Heart Journal     Open Access   (Followers: 3)
Basic Research in Cardiology     Hybrid Journal   (Followers: 9)
BMC Cardiovascular Disorders     Open Access   (Followers: 22)
Brain Circulation     Open Access   (Followers: 1)
British Journal of Cardiology     Full-text available via subscription   (Followers: 18)
Canadian Journal of Cardiology     Hybrid Journal   (Followers: 18)
Cardiac Cath Lab Director     Full-text available via subscription  
Cardiac Electrophysiology Review     Hybrid Journal   (Followers: 2)
Cardiac Failure Review     Open Access   (Followers: 2)
Cardiocore     Full-text available via subscription   (Followers: 1)
Cardiogenetics     Open Access   (Followers: 3)
Cardiology     Full-text available via subscription   (Followers: 20)
Cardiology and Angiology: An International Journal     Open Access   (Followers: 1)
Cardiology and Therapy     Open Access   (Followers: 11)
Cardiology Clinics     Full-text available via subscription   (Followers: 14)
Cardiology in Review     Hybrid Journal   (Followers: 9)
Cardiology in the Young     Hybrid Journal   (Followers: 35)
Cardiology Journal     Open Access   (Followers: 6)
Cardiology Plus     Open Access   (Followers: 1)
Cardiology Research     Open Access   (Followers: 15)
Cardiology Research and Practice     Open Access   (Followers: 11)
Cardiopulmonary Physical Therapy Journal     Hybrid Journal   (Followers: 9)
Cardiorenal Medicine     Full-text available via subscription   (Followers: 1)
Cardiothoracic Surgeon     Open Access   (Followers: 1)
CardioVasc     Full-text available via subscription   (Followers: 1)
Cardiovascular & Haematological Disorders - Drug Targets     Hybrid Journal   (Followers: 1)
Cardiovascular & Hematological Agents in Medicinal Chemistry     Hybrid Journal   (Followers: 2)
CardioVascular and Interventional Radiology     Hybrid Journal   (Followers: 15)
Cardiovascular and Thoracic Open     Open Access  
Cardiovascular Diabetology     Open Access   (Followers: 10)
Cardiovascular Drugs and Therapy     Hybrid Journal   (Followers: 14)
Cardiovascular Endocrinology & Metabolism     Hybrid Journal   (Followers: 1)
Cardiovascular Engineering     Hybrid Journal   (Followers: 1)
Cardiovascular Engineering and Technology     Hybrid Journal   (Followers: 1)
Cardiovascular Intervention and Therapeutics     Hybrid Journal   (Followers: 5)
Cardiovascular Journal     Open Access   (Followers: 6)
Cardiovascular Journal of Africa     Full-text available via subscription   (Followers: 5)
Cardiovascular Journal of South Africa     Full-text available via subscription   (Followers: 2)
Cardiovascular Medicine in General Practice     Full-text available via subscription   (Followers: 7)
Cardiovascular Pathology     Hybrid Journal   (Followers: 4)
Cardiovascular Regenerative Medicine     Open Access  
Cardiovascular Research     Hybrid Journal   (Followers: 16)
Cardiovascular Revascularization Medicine     Hybrid Journal   (Followers: 1)
Cardiovascular System     Open Access  
Cardiovascular Therapeutics     Open Access   (Followers: 1)
Cardiovascular Toxicology     Hybrid Journal   (Followers: 6)
Cardiovascular Ultrasound     Open Access   (Followers: 5)
Case Reports in Cardiology     Open Access   (Followers: 7)
Catheterization and Cardiovascular Interventions     Hybrid Journal   (Followers: 3)
Cerebrovascular Diseases     Full-text available via subscription   (Followers: 3)
Cerebrovascular Diseases Extra     Open Access  
Chest     Full-text available via subscription   (Followers: 104)
Choroby Serca i Naczyń     Open Access   (Followers: 1)
Circulation     Hybrid Journal   (Followers: 269)
Circulation : Cardiovascular Imaging     Hybrid Journal   (Followers: 15)
Circulation : Cardiovascular Interventions     Hybrid Journal   (Followers: 19)
Circulation : Cardiovascular Quality and Outcomes     Hybrid Journal   (Followers: 12)
Circulation : Genomic and Precision Medicine     Hybrid Journal   (Followers: 17)
Circulation : Heart Failure     Hybrid Journal   (Followers: 28)
Circulation Research     Hybrid Journal   (Followers: 36)
Cirugía Cardiovascular     Open Access  
Clínica e Investigación en Arteriosclerosis     Full-text available via subscription  
Clínica e Investigación en arteriosclerosis (English Edition)     Hybrid Journal  
Clinical and Experimental Hypertension     Hybrid Journal   (Followers: 3)
Clinical Cardiology     Hybrid Journal   (Followers: 10)
Clinical Hypertension     Open Access   (Followers: 5)
Clinical Medicine Insights : Cardiology     Open Access   (Followers: 6)
Clinical Research in Cardiology     Hybrid Journal   (Followers: 5)
Clinical Research in Cardiology Supplements     Hybrid Journal  
Clinical Trials and Regulatory Science in Cardiology     Open Access   (Followers: 4)
Congenital Heart Disease     Hybrid Journal   (Followers: 6)
Congestive Heart Failure     Hybrid Journal   (Followers: 4)
Cor et Vasa     Full-text available via subscription   (Followers: 1)
Coronary Artery Disease     Hybrid Journal   (Followers: 3)
CorSalud     Open Access  
Critical Pathways in Cardiology     Hybrid Journal   (Followers: 5)
Current Cardiology Reports     Hybrid Journal   (Followers: 6)
Current Cardiology Reviews     Hybrid Journal   (Followers: 3)
Current Cardiovascular Imaging Reports     Hybrid Journal   (Followers: 1)
Current Cardiovascular Risk Reports     Hybrid Journal  
Current Heart Failure Reports     Hybrid Journal   (Followers: 5)
Current Hypertension Reports     Hybrid Journal   (Followers: 6)
Current Hypertension Reviews     Hybrid Journal   (Followers: 6)
Current Opinion in Cardiology     Hybrid Journal   (Followers: 13)
Current Problems in Cardiology     Hybrid Journal   (Followers: 3)
Current Research : Cardiology     Full-text available via subscription   (Followers: 1)
Current Treatment Options in Cardiovascular Medicine     Hybrid Journal   (Followers: 1)
Current Vascular Pharmacology     Hybrid Journal   (Followers: 5)
CVIR Endovascular     Open Access   (Followers: 1)
Der Kardiologe     Hybrid Journal   (Followers: 1)
Echo Research and Practice     Open Access   (Followers: 2)
Echocardiography     Hybrid Journal   (Followers: 4)
Egyptian Heart Journal     Open Access   (Followers: 2)
Egyptian Journal of Cardiothoracic Anesthesia     Open Access  
ESC Heart Failure     Open Access   (Followers: 4)
European Cardiology Review     Open Access   (Followers: 1)
European Heart Journal     Hybrid Journal   (Followers: 68)
European Heart Journal - Cardiovascular Imaging     Hybrid Journal   (Followers: 10)
European Heart Journal - Cardiovascular Pharmacotherapy     Full-text available via subscription   (Followers: 2)
European Heart Journal - Quality of Care and Clinical Outcomes     Hybrid Journal  
European Heart Journal : Acute Cardiovascular Care     Hybrid Journal   (Followers: 1)
European Heart Journal : Case Reports     Open Access   (Followers: 1)
European Heart Journal Supplements     Hybrid Journal   (Followers: 7)
European Journal of Cardio-Thoracic Surgery     Hybrid Journal   (Followers: 9)
European Journal of Cardio-Thoracic Surgery Supplements     Full-text available via subscription   (Followers: 2)
European Journal of Cardiovascular Nursing     Hybrid Journal   (Followers: 5)
European Journal of Heart Failure     Hybrid Journal   (Followers: 13)
European Journal of Preventive Cardiology.     Hybrid Journal   (Followers: 6)
European Stroke Organisation     Hybrid Journal   (Followers: 3)
Experimental & Translational Stroke Medicine     Open Access   (Followers: 9)
Expert Review of Cardiovascular Therapy     Full-text available via subscription   (Followers: 3)
Folia Cardiologica     Open Access  
Forum Zaburzeń Metabolicznych     Hybrid Journal  
Frontiers in Cardiovascular Medicine     Open Access   (Followers: 1)
Future Cardiology     Hybrid Journal   (Followers: 5)
General Thoracic and Cardiovascular Surgery     Hybrid Journal   (Followers: 3)
Global Cardiology Science and Practice     Open Access   (Followers: 5)
Global Heart     Hybrid Journal   (Followers: 3)
Heart     Hybrid Journal   (Followers: 49)
Heart and Mind     Open Access  
Heart and Vessels     Hybrid Journal  
Heart Failure Clinics     Full-text available via subscription   (Followers: 2)
Heart Failure Reviews     Hybrid Journal   (Followers: 3)
Heart India     Open Access   (Followers: 2)
Heart International     Full-text available via subscription  
Heart Rhythm     Hybrid Journal   (Followers: 11)
Heart Views     Open Access   (Followers: 2)
HeartRhythm Case Reports     Open Access  
Hellenic Journal of Cardiology     Open Access   (Followers: 1)
Herz     Hybrid Journal   (Followers: 2)
High Blood Pressure & Cardiovascular Prevention     Full-text available via subscription   (Followers: 2)
Hypertension     Full-text available via subscription   (Followers: 24)
Hypertension     Open Access   (Followers: 2)
Hypertension in Pregnancy     Hybrid Journal   (Followers: 9)
Hypertension Research     Hybrid Journal   (Followers: 4)
Ibrahim Cardiac Medical Journal     Open Access  
IJC Heart & Vessels     Open Access   (Followers: 1)
IJC Heart & Vasculature     Open Access   (Followers: 1)
IJC Metabolic & Endocrine     Open Access   (Followers: 1)
Indian Heart Journal     Open Access   (Followers: 5)
Indian Journal of Cardiovascular Disease in Women WINCARS     Open Access  
Indian Journal of Thoracic and Cardiovascular Surgery     Hybrid Journal  
Indian Pacing and Electrophysiology Journal     Open Access   (Followers: 1)
Innovations : Technology and Techniques in Cardiothoracic and Vascular Surgery     Hybrid Journal   (Followers: 1)
Insuficiencia Cardíaca     Open Access  
Interactive CardioVascular and Thoracic Surgery     Hybrid Journal   (Followers: 6)
International Cardiovascular Forum Journal     Open Access  
International Journal of Angiology     Hybrid Journal   (Followers: 2)
International Journal of Cardiology     Hybrid Journal   (Followers: 17)
International Journal of Cardiology Hypertension     Open Access   (Followers: 1)
International Journal of Cardiovascular and Cerebrovascular Disease     Open Access   (Followers: 3)
International Journal of Cardiovascular Imaging     Hybrid Journal   (Followers: 2)
International Journal of Cardiovascular Research     Hybrid Journal   (Followers: 6)
International Journal of Heart Rhythm     Open Access  
International Journal of Hypertension     Open Access   (Followers: 8)
International Journal of Hyperthermia     Open Access  
International Journal of Stroke     Hybrid Journal   (Followers: 33)
International Journal of the Cardiovascular Academy     Open Access  
Interventional Cardiology Clinics     Full-text available via subscription   (Followers: 2)
Interventional Cardiology Review     Open Access  
JACC : Basic to Translational Science     Open Access   (Followers: 6)
JACC : Cardiovascular Imaging     Hybrid Journal   (Followers: 19)
JACC : Cardiovascular Interventions     Hybrid Journal   (Followers: 21)
JACC : Heart Failure     Full-text available via subscription   (Followers: 16)
JAMA Cardiology     Hybrid Journal   (Followers: 31)

        1 2 | Last

Similar Journals
Journal Cover
JAMA Cardiology
Journal Prestige (SJR): 5.551
Citation Impact (citeScore): 5
Number of Followers: 31  
 
  Hybrid Journal Hybrid journal (It can contain Open Access articles)
ISSN (Online) 2380-6583
Published by American Medical Association Homepage  [14 journals]
  • JAMA Cardiology
    • Pages: 741 - 741
      Abstract: Mission Statement: JAMA Cardiology publishes exceptional original research, state-of-the-art reviews, and informative opinions that advance the science and practice of cardiology, enhance cardiovascular health, and inform health care policy. JAMA Cardiology is the definitive journal for clinical investigators, clinicians, and trainees in cardiovascular medicine worldwide. JAMA Cardiology focuses on all aspects of cardiovascular medicine, including epidemiology and prevention, diagnostic testing, interventional and pharmacologic therapeutics, translational research, health care policy and outcomes, and global health.
      PubDate: Wed, 01 Jul 2020 00:00:00 GMT
      DOI: 10.1001/jamacardio.2019.3465
      Issue No: Vol. 5, No. 7 (2020)
       
  • Acute Respiratory Infection and the Most Common Noncommunicable
           Epidemic—COVID-19 and Cardiovascular Diseases
    • Authors: Yang C; Jin Z.
      Pages: 743 - 744
      Abstract: This Viewpoint discusses the evidence of pathophysiological and epidemiological connections between COVID-19 and cardiovascular diseases and treatments.
      PubDate: Wed, 01 Jul 2020 00:00:00 GMT
      DOI: 10.1001/jamacardio.2020.0934
      Issue No: Vol. 5, No. 7 (2020)
       
  • Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System
           Blockers
    • Authors: Bavishi C; Maddox TM, Messerli FH.
      Pages: 745 - 747
      Abstract: This Viewpoint discusses recommendations for angiotensin-converting enzyme inhibitor and angiotensin receptor blocker use in patients with or at risk of contracting coronavirus disease 2019 (COVID-19).
      PubDate: Wed, 01 Jul 2020 00:00:00 GMT
      DOI: 10.1001/jamacardio.2020.1282
      Issue No: Vol. 5, No. 7 (2020)
       
  • The Dilemma of COVID-19, Aging, and Cardiovascular Disease
    • Authors: AlGhatrif M; Cingolani O, Lakatta EG.
      Pages: 747 - 748
      Abstract: This Viewpoint discusses whether individuals should continue to take angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the context of coronavirus disease 2019 (COVID-19).
      PubDate: Wed, 01 Jul 2020 00:00:00 GMT
      DOI: 10.1001/jamacardio.2020.1329
      Issue No: Vol. 5, No. 7 (2020)
       
  • Fellowship in the Time of COVID-19: A Time to Adapt
    • Authors: Chau KH; Nouri S, Madhavan MV.
      Pages: 749 - 750
      Abstract: This essay describes how the authors’ fellowship training has changed because of the coronavirus disease 2019 (COVID-19) pandemic.
      PubDate: Wed, 01 Jul 2020 00:00:00 GMT
      DOI: 10.1001/jamacardio.2020.1562
      Issue No: Vol. 5, No. 7 (2020)
       
  • Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury
           and Mortality
    • Authors: Bonow RO; Fonarow GC, O’Gara PT, et al.
      Pages: 751 - 753
      Abstract: Coronavirus disease 2019 (COVID-19) has emerged as a pandemic and a public health crisis of global proportions. As a medical community, we are actively engaged in a real-time data gathering mode to facilitate active learning and an expedited study of best practices of care. Although we are becoming more aware of the natural history of COVID-19, we have had scant information as of yet that addresses any unique risks of COVID-19 for those with underlying cardiovascular disease. Such information is of paramount importance as we now must begin to consider the potential for direct and indirect adverse effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the heart and especially so in those with already established heart disease.
      PubDate: Wed, 01 Jul 2020 00:00:00 GMT
      DOI: 10.1001/jamacardio.2020.1105
      Issue No: Vol. 5, No. 7 (2020)
       
  • Sex Differences in Ischemic Heart Disease—the Paradox Persists
    • Authors: Mendirichaga R; Jacobs AK.
      Pages: 754 - 756
      Abstract: Over the past 4 decades, numerous studies, including randomized clinical trials and registry data, have reported remarkably consistent sex-based differences in clinical, angiographic, and procedural characteristics as well as in outcomes across the spectrum of ischemic heart disease. Women are older with a higher prevalence of risk factors and comorbid disease, less prior myocardial infarction (MI), fewer revascularization procedures, a higher incidence of heart failure despite preserved left ventricular systolic function, and less extensive epicardial coronary artery disease (CAD) (Figure) yet more symptoms compared with men. Women are treated with fewer evidence-based therapies and have worse outcomes, including higher complication and mortality rates. With increasing awareness and interest in these biologic differences (or disparities in care), outcomes in women are improving. However, the paradox between risk factors, the extent of CAD, and the degree of symptoms persists.
      PubDate: Wed, 01 Jul 2020 00:00:00 GMT
      DOI: 10.1001/jamacardio.2020.0819
      Issue No: Vol. 5, No. 7 (2020)
       
  • Limitations to Optimization of Guideline-Directed Medical Therapy in Heart
           Failure
    • Authors: Fiuzat M; Ezekowitz J, Alemayehu W, et al.
      Pages: 757 - 764
      Abstract: This secondary analysis of a randomized clinical trial examines medical therapy and reasons why an intervention did not work for patients with heart failure in the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment.
      PubDate: Wed, 01 Jul 2020 00:00:00 GMT
      DOI: 10.1001/jamacardio.2020.0640
      Issue No: Vol. 5, No. 7 (2020)
       
  • Procedural Mortality Compared With Disease-Based Mortality in Patients
           With Acute Myocardial Infarction
    • Authors: Nathan AS; Xiang Q, Wojdyla D, et al.
      Pages: 765 - 772
      Abstract: This cross-sectional study examines correlation and reclassification between hospital-level disease-specific mortality and percutaneous coronary intervention procedural mortality among patients with acute myocardial infarction.
      PubDate: Wed, 01 Jul 2020 00:00:00 GMT
      DOI: 10.1001/jamacardio.2020.0753
      Issue No: Vol. 5, No. 7 (2020)
       
  • Association of Sex With Coronary Artery Disease, Ischemia, and Symptom
           Burden in Patients With Ischemia
    • Authors: Reynolds HR; Shaw LJ, Min JK, et al.
      Pages: 773 - 786
      Abstract: This secondary analysis of the ISCHEMIA randomized clinical trial describes sex differences in stress testing, coronary computed tomographic angiography findings, and symptoms in patients with stable ischemic heart disease.
      PubDate: Wed, 01 Jul 2020 00:00:00 GMT
      DOI: 10.1001/jamacardio.2020.0822
      Issue No: Vol. 5, No. 7 (2020)
       
  • Effect of Evolocumab on Type and Size of Subsequent Myocardial Infarction
    • Authors: Wiviott SD; Giugliano RP, Morrow DA, et al.
      Pages: 787 - 793
      Abstract: This prespecified analysis of a randomized clinical trial evaluates the effect of evolocumab on type and size of subsequent myocardial infarction.
      PubDate: Wed, 01 Jul 2020 00:00:00 GMT
      DOI: 10.1001/jamacardio.2020.0764
      Issue No: Vol. 5, No. 7 (2020)
       
  • Toward a More Detailed Reporting of MI Reduction in Clinical Trials
    • Authors: Levine GN.
      Pages: 793 - 794
      Abstract: In the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) trial, a total of 27 564 patients with clinically evident atherosclerotic cardiovascular disease already receiving statin therapy were randomized to receive either additional lipid-lowering therapy with evolocumab or to placebo. The broad primary composite end point of cardiovascular events, that included cardiovascular death, myocardial infarction, stroke, hospitalization for unstable angina, or coronary revascularization, was reduced from 11.3% in patients treated with placebo to 9.8% in patients treated with evolocumab. Aside from cardiovascular death, which is obviously the most important and hardest clinical end point in the trial, many clinicians, academicians, health care organization and insurance company administrators, guideline formulators, and policy makers focused attention on reduction in myocardial infarction (MI). In the primary FOURIER results publication, however, no criteria for the diagnosis of MI are given (presumably due to word count considerations), and in the supplementary appendix one learns that diagnostic biomarker elevation is defined as any elevation above the 99th percentile of the upper reference limit. One is left to wonder about the type, size, and clinical significance of such MIs that were prevented with evolocumab in this trial.
      PubDate: Wed, 01 Jul 2020 00:00:00 GMT
      DOI: 10.1001/jamacardio.2020.0749
      Issue No: Vol. 5, No. 7 (2020)
       
  • Association Between Blood Pressure Variability and Myocardial Structure
           and Function
    • Authors: Nwabuo CC; Yano Y, Moreira HT, et al.
      Pages: 795 - 801
      Abstract: This cohort study examines the association between blood pressure variability in early adulthood and myocardial structure and function in middle age.
      PubDate: Wed, 01 Jul 2020 00:00:00 GMT
      DOI: 10.1001/jamacardio.2020.0799
      Issue No: Vol. 5, No. 7 (2020)
       
  • Association of Cardiac Injury With Mortality in Hospitalized Patients With
           COVID-19 in Wuhan, China
    • Authors: Shi S; Qin M, Shen B, et al.
      Pages: 802 - 810
      Abstract: This cohort study, conducted from January 20, 2020, to February 10, 2020, in Wuhan, China, explores the prevalence of cardiac injury in hospitalized patients with COVID-19 and its association with mortality.
      PubDate: Wed, 01 Jul 2020 00:00:00 GMT
      DOI: 10.1001/jamacardio.2020.0950
      Issue No: Vol. 5, No. 7 (2020)
       
  • Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus
           Disease 2019 (COVID-19)
    • Authors: Guo T; Fan Y, Chen M, et al.
      Pages: 811 - 818
      Abstract: This case series study evaluates the association of underlying cardiovascular disease and myocardial injury on fatal outcomes in patients with coronavirus disease 2019 (COVID-19).
      PubDate: Wed, 01 Jul 2020 00:00:00 GMT
      DOI: 10.1001/jamacardio.2020.1017
      Issue No: Vol. 5, No. 7 (2020)
       
  • Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)
    • Authors: Inciardi RM; Lupi L, Zaccone G, et al.
      Pages: 819 - 824
      Abstract: This case report describes the presentation of acute myocardial inflammation in a patient with coronavirus disease 2019 (COVID-19) who recovered from influenzalike syndrome and developed fatigue and signs and symptoms of heart failure a week after upper respiratory tract symptoms.
      PubDate: Wed, 01 Jul 2020 00:00:00 GMT
      DOI: 10.1001/jamacardio.2020.1096
      Issue No: Vol. 5, No. 7 (2020)
       
  • Renin-Angiotensin System Inhibitors and Severity or Risk of Death in
           Patients With Hypertension Hospitalized for COVID-19
    • Authors: Li J; Wang X, Chen J, et al.
      Pages: 825 - 830
      Abstract: This cohort study examines the association between angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and severity of illness and mortality in patients with hypertension hospitalized for COVID-19 infection.
      PubDate: Wed, 01 Jul 2020 00:00:00 GMT
      DOI: 10.1001/jamacardio.2020.1624
      Issue No: Vol. 5, No. 7 (2020)
       
  • Potential Effects of Coronaviruses on the Cardiovascular System
    • Authors: Madjid M; Safavi-Naeini P, Solomon SD, et al.
      Pages: 831 - 840
      Abstract: This narrative review provides an overview of the basics of coronaviruses, with a focus on coronavirus disease 2019 along with their effects on the cardiovascular system.
      PubDate: Wed, 01 Jul 2020 00:00:00 GMT
      DOI: 10.1001/jamacardio.2020.1286
      Issue No: Vol. 5, No. 7 (2020)
       
  • A Young Man in His 20s With New-onset Severe Heart Failure and Ventricular
           Tachycardia
    • Authors: Warraich H; Manly D.
      Pages: 841 - 841
      Abstract: This case report describes a man in his 20s with severe heart failure, ventricular arrhythmias, and unrevealing biopsy.
      PubDate: Wed, 01 Jul 2020 00:00:00 GMT
      DOI: 10.1001/jamacardio.2020.1054
      Issue No: Vol. 5, No. 7 (2020)
       
  • A Woman in Her 50s With Dyspnea, Palpitation, and Severely Elevated
           Pulmonary Artery Pressure
    • Authors: Lau Y; Tse H.
      Pages: 842 - 842
      Abstract: This case report describes a left atrial mass suspected to be an intracardiac thrombus.
      PubDate: Wed, 01 Jul 2020 00:00:00 GMT
      DOI: 10.1001/jamacardio.2020.1048
      Issue No: Vol. 5, No. 7 (2020)
       
  • An Unusual Electrocardiogram Following Pacemaker Implantation
    • Authors: Mayfield JJ; Goldschlager N.
      Pages: 843 - 844
      Abstract: A man in his 30s presented for follow-up of a newly installed pacemaker, and electrocardiography resulted in an unusual image. What would you do next'
      PubDate: Wed, 01 Jul 2020 00:00:00 GMT
      DOI: 10.1001/jamacardio.2020.1061
      Issue No: Vol. 5, No. 7 (2020)
       
  • Digital Informed Consent in a Rural and Low-Income Population
    • Authors: Clark D; III, Woods J, Patki D, et al.
      Pages: 845 - 847
      Abstract: This cohort study examines a process of digitized informed consent for the enrollment of a rural population in research.
      PubDate: Wed, 01 Jul 2020 00:00:00 GMT
      DOI: 10.1001/jamacardio.2020.0984
      Issue No: Vol. 5, No. 7 (2020)
       
  • Initial Monthly Cost of Tafamidis—the Real Price for Patients
    • Authors: Cuddy SM; Coyle ML, Falk RH.
      Pages: 847 - 848
      Abstract: To the Editor We concur entirely with the Viewpoint by Gurwitz and Maurer on the high price of tafamidis for the treatment of transthyretin amyloidosis cardiomyopathy (ATTR-CM). The authors briefly addressed the potential problem of access and affordability for patients but do not provide details on cost. As this is a disease of the elderly, most patients in the US receiving tafamidis are Medicare beneficiaries. Medicare has a multilayered structure for drug coverage, and patients may be subject to high copayments, which vary depending on several factors, including supplemental insurance. For those with a high copayment, pharmaceutical company–sponsored, income-based financial assistance may be available, and charitable foundations inconsistently have available funds, but both are on a year-to-year basis.
      PubDate: Wed, 01 Jul 2020 00:00:00 GMT
      DOI: 10.1001/jamacardio.2020.0863
      Issue No: Vol. 5, No. 7 (2020)
       
  • Error in Text
    • Pages: 848 - 848
      Abstract: In the Original Investigation titled “Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19),” published online March 27, 2020, errors appeared in the Abstract and Results section. The number of patients with elevated troponin T levels using mechnical ventilation is 31, rather than 41. In addition, the mortality rate of patients without use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is 21.4% (36 of 168) (P = .13). The article has been corrected online.
      PubDate: Wed, 01 Jul 2020 00:00:00 GMT
      DOI: 10.1001/jamacardio.2020.1722
      Issue No: Vol. 5, No. 7 (2020)
       
  • Initial Monthly Cost of Tafamidis—the Real Price for
           Patients—Reply
    • Authors: Gurwitz JH; Maurer MS.
      Pages: 848 - 848
      Abstract: In Reply In commenting on our Viewpoint, Cuddy et al describe the real price of tafamidis for patients with transthyretin amyloid cardiomyopathy (ATTR-CM) cared for at their institution. The findings underscore that insurance coverage for prescription medications and patient assistance programs run by pharmaceutical companies do not shield patients from high drug prices. David Mitchell, founder of Patients for Affordable Drugs, has stated, “drugs don’t work if people can’t afford them”; “innovation and new drugs should not come at prices that bankrupt people…when they are struggling to maintain their health.”
      PubDate: Wed, 01 Jul 2020 00:00:00 GMT
      DOI: 10.1001/jamacardio.2020.0866
      Issue No: Vol. 5, No. 7 (2020)
       
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
 


Your IP address: 3.228.220.31
 
Home (Search)
API
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-